ID   BRSK1_HUMAN             Reviewed;         778 AA.
AC   Q8TDC3; F1DG44; Q5J5B5; Q8NDD0; Q8NDR4; Q8TDC2; Q96AV4; Q96JL4;
DT   29-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   21-SEP-2011, sequence version 2.
DT   12-OCT-2022, entry version 184.
DE   RecName: Full=Serine/threonine-protein kinase BRSK1;
DE            EC=2.7.11.1;
DE   AltName: Full=Brain-selective kinase 1;
DE            EC=2.7.11.26;
DE   AltName: Full=Brain-specific serine/threonine-protein kinase 1;
DE            Short=BR serine/threonine-protein kinase 1;
DE   AltName: Full=Serine/threonine-protein kinase SAD-B;
DE   AltName: Full=Synapses of Amphids Defective homolog 1;
DE            Short=SAD1 homolog;
DE            Short=hSAD1;
GN   Name=BRSK1; Synonyms=KIAA1811, SAD1, SADB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, ACTIVITY REGULATION,
RP   PHOSPHORYLATION AT THR-189, AND MUTAGENESIS OF THR-189.
RX   PubMed=14976552; DOI=10.1038/sj.emboj.7600110;
RA   Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A., Boudeau J.,
RA   Hawley S.A., Udd L., Maekelae T.P., Hardie D.G., Alessi D.R.;
RT   "LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily,
RT   including MARK/PAR-1.";
RL   EMBO J. 23:833-843(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, AND MUTAGENESIS OF LYS-59.
RC   TISSUE=Testis;
RX   PubMed=15150265; DOI=10.1074/jbc.m404728200;
RA   Lu R., Niida H., Nakanishi M.;
RT   "Human SAD1 kinase is involved in UV-induced DNA damage checkpoint
RT   function.";
RL   J. Biol. Chem. 279:31164-31170(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=16630837; DOI=10.1016/j.neuron.2006.03.018;
RA   Inoue E., Mochida S., Takagi H., Higa S., Deguchi-Tawarada M.,
RA   Takao-Rikitsu E., Inoue M., Yao I., Takeuchi K., Kitajima I., Setou M.,
RA   Ohtsuka T., Takai Y.;
RT   "SAD: a presynaptic kinase associated with synaptic vesicles and the active
RT   zone cytomatrix that regulates neurotransmitter release.";
RL   Neuron 50:261-275(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=19648910; DOI=10.1038/ncb1921;
RA   Alvarado-Kristensson M., Rodriguez M.J., Silio V., Valpuesta J.M.,
RA   Carrera A.C.;
RT   "SADB phosphorylation of gamma-tubulin regulates centrosome duplication.";
RL   Nat. Cell Biol. 11:1081-1092(2009).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RA   She X.Y., Yu L., Guo J.H.;
RL   Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 35-778.
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 64-778.
RC   TISSUE=Brain;
RX   PubMed=11347906; DOI=10.1093/dnares/8.2.85;
RA   Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XX. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 8:85-95(2001).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 287-778.
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PHOSPHORYLATION AT THR-189, AND MUTAGENESIS OF GLY-327.
RX   PubMed=18339622; DOI=10.1074/jbc.m710381200;
RA   Bright N.J., Carling D., Thornton C.;
RT   "Investigating the regulation of brain-specific kinases 1 and 2 by
RT   phosphorylation.";
RL   J. Biol. Chem. 283:14946-14954(2008).
RN   [11]
RP   PHOSPHORYLATION.
RX   PubMed=19958286; DOI=10.1042/bj20091372;
RA   Fogarty S., Hawley S.A., Green K.A., Saner N., Mustard K.J., Hardie D.G.;
RT   "Calmodulin-dependent protein kinase kinase-beta activates AMPK without
RT   forming a stable complex: synergistic effects of Ca2+ and AMP.";
RL   Biochem. J. 426:109-118(2010).
RN   [12]
RP   FUNCTION.
RX   PubMed=20026642; DOI=10.1242/jcs.058230;
RA   Muller M., Lutter D., Puschel A.W.;
RT   "Persistence of the cell-cycle checkpoint kinase Wee1 in SadA- and SadB-
RT   deficient neurons disrupts neuronal polarity.";
RL   J. Cell Sci. 123:286-294(2010).
RN   [13]
RP   CATALYTIC ACTIVITY, AND FUNCTION IN MAPT PHOSPHORYLATION.
RX   PubMed=21985311; DOI=10.1111/j.1471-4159.2011.07523.x;
RA   Yoshida H., Goedert M.;
RT   "Phosphorylation of microtubule-associated protein tau by AMPK-related
RT   kinases.";
RL   J. Neurochem. 120:165-176(2012).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-508, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] TRP-303; ILE-319; GLU-391; ASN-531; SER-749
RP   AND ALA-764.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase that plays a key role in
CC       polarization of neurons and centrosome duplication. Phosphorylates
CC       CDC25B, CDC25C, MAPT/TAU, RIMS1, TUBG1, TUBG2 and WEE1. Following
CC       phosphorylation and activation by STK11/LKB1, acts as a key regulator
CC       of polarization of cortical neurons, probably by mediating
CC       phosphorylation of microtubule-associated proteins such as MAPT/TAU at
CC       'Thr-529' and 'Ser-579'. Also regulates neuron polarization by
CC       mediating phosphorylation of WEE1 at 'Ser-642' in postmitotic neurons,
CC       leading to down-regulate WEE1 activity in polarized neurons. In
CC       neurons, localizes to synaptic vesicles and plays a role in
CC       neurotransmitter release, possibly by phosphorylating RIMS1. Also acts
CC       as a positive regulator of centrosome duplication by mediating
CC       phosphorylation of gamma-tubulin (TUBG1 and TUBG2) at 'Ser-131',
CC       leading to translocation of gamma-tubulin and its associated proteins
CC       to the centrosome. Involved in the UV-induced DNA damage checkpoint
CC       response, probably by inhibiting CDK1 activity through phosphorylation
CC       and activation of WEE1, and inhibition of CDC25B and CDC25C.
CC       {ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:15150265,
CC       ECO:0000269|PubMed:20026642, ECO:0000269|PubMed:21985311}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:21985311};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:21985311};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[tau protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [tau protein]; Xref=Rhea:RHEA:12801, Rhea:RHEA-COMP:13701, Rhea:RHEA-
CC         COMP:13702, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.26;
CC         Evidence={ECO:0000269|PubMed:21985311};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[tau protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[tau protein]; Xref=Rhea:RHEA:53904, Rhea:RHEA-COMP:13703,
CC         Rhea:RHEA-COMP:13704, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.26; Evidence={ECO:0000269|PubMed:21985311};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ACTIVITY REGULATION: Activated by phosphorylation on Thr-189 by
CC       STK11/LKB1. {ECO:0000269|PubMed:14976552}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15150265}. Nucleus
CC       {ECO:0000269|PubMed:15150265}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000250}. Synapse
CC       {ECO:0000250|UniProtKB:B2DD29}. Presynaptic active zone
CC       {ECO:0000250|UniProtKB:B2DD29}. Cytoplasmic vesicle, secretory vesicle,
CC       synaptic vesicle {ECO:0000250|UniProtKB:B2DD29}. Note=Nuclear in the
CC       absence of DNA damage. Translocated to the nucleus in response to
CC       UV- or MMS-induced DNA damage (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=SADB-Long, L;
CC         IsoId=Q8TDC3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TDC3-2; Sequence=VSP_008158;
CC       Name=3; Synonyms=SADB-short, S;
CC         IsoId=Q8TDC3-3; Sequence=VSP_041742;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest levels in brain and
CC       testis. Protein levels remain constant throughout the cell cycle.
CC       {ECO:0000269|PubMed:15150265}.
CC   -!- PTM: Phosphorylated at Thr-189 by STK11/LKB1 in complex with STE20-
CC       related adapter-alpha (STRADA) pseudo kinase and CAB39. Not
CC       phosphorylated at Thr-189 by CaMKK2. In contrast, it is phosphorylated
CC       and activated by CaMKK1. May be inactivated via dephosphorylation of
CC       Thr-189 by PP2C. {ECO:0000269|PubMed:14976552,
CC       ECO:0000269|PubMed:18339622, ECO:0000269|PubMed:19958286}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. SNF1 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH16681.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY458602; AAS10354.1; -; mRNA.
DR   EMBL; AY505124; AAS86442.1; -; mRNA.
DR   EMBL; HQ830199; ADX95745.1; -; mRNA.
DR   EMBL; AF479826; AAL87697.1; -; mRNA.
DR   EMBL; AF479827; AAL87698.1; -; mRNA.
DR   EMBL; AC008974; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020922; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL831945; CAD38595.1; -; mRNA.
DR   EMBL; AL834275; CAD38950.2; -; mRNA.
DR   EMBL; AB058714; BAB47440.1; -; mRNA.
DR   EMBL; BC016681; AAH16681.1; ALT_INIT; mRNA.
DR   CCDS; CCDS12921.1; -. [Q8TDC3-1]
DR   RefSeq; NP_115806.1; NM_032430.1. [Q8TDC3-1]
DR   AlphaFoldDB; Q8TDC3; -.
DR   SMR; Q8TDC3; -.
DR   BioGRID; 124084; 10.
DR   IntAct; Q8TDC3; 24.
DR   MINT; Q8TDC3; -.
DR   STRING; 9606.ENSP00000310649; -.
DR   BindingDB; Q8TDC3; -.
DR   ChEMBL; CHEMBL5650; -.
DR   DrugCentral; Q8TDC3; -.
DR   GlyGen; Q8TDC3; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8TDC3; -.
DR   PhosphoSitePlus; Q8TDC3; -.
DR   BioMuta; BRSK1; -.
DR   DMDM; 347595639; -.
DR   jPOST; Q8TDC3; -.
DR   MassIVE; Q8TDC3; -.
DR   PaxDb; Q8TDC3; -.
DR   PeptideAtlas; Q8TDC3; -.
DR   PRIDE; Q8TDC3; -.
DR   ProteomicsDB; 74264; -. [Q8TDC3-1]
DR   ProteomicsDB; 74265; -. [Q8TDC3-2]
DR   ProteomicsDB; 74266; -. [Q8TDC3-3]
DR   Antibodypedia; 19545; 474 antibodies from 35 providers.
DR   DNASU; 84446; -.
DR   Ensembl; ENST00000309383.6; ENSP00000310649.1; ENSG00000160469.17. [Q8TDC3-1]
DR   Ensembl; ENST00000585418.1; ENSP00000467357.1; ENSG00000160469.17. [Q8TDC3-3]
DR   Ensembl; ENST00000590333.5; ENSP00000468190.1; ENSG00000160469.17. [Q8TDC3-2]
DR   GeneID; 84446; -.
DR   KEGG; hsa:84446; -.
DR   MANE-Select; ENST00000309383.6; ENSP00000310649.1; NM_032430.2; NP_115806.1.
DR   UCSC; uc002qkf.4; human. [Q8TDC3-1]
DR   CTD; 84446; -.
DR   DisGeNET; 84446; -.
DR   GeneCards; BRSK1; -.
DR   HGNC; HGNC:18994; BRSK1.
DR   HPA; ENSG00000160469; Group enriched (brain, pituitary gland).
DR   MIM; 609235; gene.
DR   neXtProt; NX_Q8TDC3; -.
DR   OpenTargets; ENSG00000160469; -.
DR   PharmGKB; PA134888976; -.
DR   VEuPathDB; HostDB:ENSG00000160469; -.
DR   eggNOG; KOG0588; Eukaryota.
DR   GeneTree; ENSGT00940000161254; -.
DR   HOGENOM; CLU_000288_156_2_1; -.
DR   InParanoid; Q8TDC3; -.
DR   OMA; LFALLVX; -.
DR   OrthoDB; 1127668at2759; -.
DR   PhylomeDB; Q8TDC3; -.
DR   TreeFam; TF313967; -.
DR   PathwayCommons; Q8TDC3; -.
DR   SignaLink; Q8TDC3; -.
DR   SIGNOR; Q8TDC3; -.
DR   BioGRID-ORCS; 84446; 8 hits in 1109 CRISPR screens.
DR   ChiTaRS; BRSK1; human.
DR   GeneWiki; BRSK1; -.
DR   GenomeRNAi; 84446; -.
DR   Pharos; Q8TDC3; Tchem.
DR   PRO; PR:Q8TDC3; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q8TDC3; protein.
DR   Bgee; ENSG00000160469; Expressed in right frontal lobe and 120 other tissues.
DR   ExpressionAtlas; Q8TDC3; baseline and differential.
DR   Genevisible; Q8TDC3; HS.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005813; C:centrosome; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0150034; C:distal axon; ISS:ARUK-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048786; C:presynaptic active zone; TAS:ARUK-UCL.
DR   GO; GO:0008021; C:synaptic vesicle; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IC:UniProtKB.
DR   GO; GO:0043015; F:gamma-tubulin binding; ISS:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0048156; F:tau protein binding; NAS:ARUK-UCL.
DR   GO; GO:0050321; F:tau-protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0008306; P:associative learning; ISS:ARUK-UCL.
DR   GO; GO:0007409; P:axonogenesis; ISS:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IBA:GO_Central.
DR   GO; GO:0051298; P:centrosome duplication; ISS:UniProtKB.
DR   GO; GO:0030010; P:establishment of cell polarity; ISS:UniProtKB.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:MGI.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0090176; P:microtubule cytoskeleton organization involved in establishment of planar polarity; ISS:ARUK-UCL.
DR   GO; GO:0007095; P:mitotic G2 DNA damage checkpoint signaling; IDA:UniProtKB.
DR   GO; GO:0030182; P:neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0007269; P:neurotransmitter secretion; ISS:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:MGI.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0050770; P:regulation of axonogenesis; ISS:ARUK-UCL.
DR   GO; GO:0010975; P:regulation of neuron projection development; ISS:ARUK-UCL.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISS:ARUK-UCL.
DR   GO; GO:2000807; P:regulation of synaptic vesicle clustering; TAS:ARUK-UCL.
DR   GO; GO:0009411; P:response to UV; IDA:UniProtKB.
DR   GO; GO:0099504; P:synaptic vesicle cycle; ISS:ARUK-UCL.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR015940; UBA.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell cycle; Cell projection; Cytoplasm;
KW   Cytoplasmic vesicle; Cytoskeleton; DNA damage; Kinase; Magnesium;
KW   Metal-binding; Methylation; Neurogenesis; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Synapse; Transferase.
FT   CHAIN           1..778
FT                   /note="Serine/threonine-protein kinase BRSK1"
FT                   /id="PRO_0000085669"
FT   DOMAIN          34..285
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          314..356
FT                   /note="UBA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00212"
FT   REGION          1..29
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          362..548
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          719..778
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        362..401
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        426..453
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        488..510
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        512..529
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        740..758
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        156
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         40..48
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         63
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         189
FT                   /note="Phosphothreonine; by LKB1"
FT                   /evidence="ECO:0000269|PubMed:14976552,
FT                   ECO:0000269|PubMed:18339622"
FT   MOD_RES         399
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5RJI5"
FT   MOD_RES         443
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5RJI5"
FT   MOD_RES         447
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5RJI5"
FT   MOD_RES         450
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5RJI5"
FT   MOD_RES         466
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5RJI5"
FT   MOD_RES         481
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5RJI5"
FT   MOD_RES         484
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5RJI5"
FT   MOD_RES         498
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5RJI5"
FT   MOD_RES         508
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         525
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5RJI5"
FT   MOD_RES         529
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5RJI5"
FT   MOD_RES         535
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5RJI5"
FT   MOD_RES         550
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5RJI5"
FT   MOD_RES         583
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5RJI5"
FT   MOD_RES         586
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:B2DD29"
FT   MOD_RES         587
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:B2DD29"
FT   MOD_RES         601
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:B2DD29"
FT   VAR_SEQ         1..26
FT                   /note="MSSGAKEGGGGSPAYHLPHPHPHPPQ -> MVAGLTLGKGPESPDGDVSVPE
FT                   RKDEVAGGGGEEEEAEERGR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14976552, ECO:0000303|Ref.5"
FT                   /id="VSP_008158"
FT   VAR_SEQ         344..778
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:19648910"
FT                   /id="VSP_041742"
FT   VARIANT         303
FT                   /note="R -> W (in a gastric adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs144130246)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040394"
FT   VARIANT         319
FT                   /note="V -> I (in a lung large cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040395"
FT   VARIANT         391
FT                   /note="G -> E (in a metastatic melanoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040396"
FT   VARIANT         531
FT                   /note="T -> N (in dbSNP:rs55892637)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040397"
FT   VARIANT         749
FT                   /note="G -> S (in dbSNP:rs12978445)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040398"
FT   VARIANT         764
FT                   /note="P -> A (in dbSNP:rs55796422)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040399"
FT   MUTAGEN         59
FT                   /note="K->A: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:15150265"
FT   MUTAGEN         189
FT                   /note="T->A: Prevents phosphorylation and activation by
FT                   STK11/LKB1 complex."
FT                   /evidence="ECO:0000269|PubMed:14976552"
FT   MUTAGEN         327
FT                   /note="G->A: Abolishes activation of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:18339622"
FT   CONFLICT        762
FT                   /note="G -> A (in Ref. 9; AAH16681)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   778 AA;  85087 MW;  8D1818D4E54398BB CRC64;
     MSSGAKEGGG GSPAYHLPHP HPHPPQHAQY VGPYRLEKTL GKGQTGLVKL GVHCITGQKV
     AIKIVNREKL SESVLMKVER EIAILKLIEH PHVLKLHDVY ENKKYLYLVL EHVSGGELFD
     YLVKKGRLTP KEARKFFRQI VSALDFCHSY SICHRDLKPE NLLLDEKNNI RIADFGMASL
     QVGDSLLETS CGSPHYACPE VIKGEKYDGR RADMWSCGVI LFALLVGALP FDDDNLRQLL
     EKVKRGVFHM PHFIPPDCQS LLRGMIEVEP EKRLSLEQIQ KHPWYLGGKH EPDPCLEPAP
     GRRVAMRSLP SNGELDPDVL ESMASLGCFR DRERLHRELR SEEENQEKMI YYLLLDRKER
     YPSCEDQDLP PRNDVDPPRK RVDSPMLSRH GKRRPERKSM EVLSITDAGG GGSPVPTRRA
     LEMAQHSQRS RSVSGASTGL SSSPLSSPRS PVFSFSPEPG AGDEARGGGS PTSKTQTLPS
     RGPRGGGAGE QPPPPSARST PLPGPPGSPR SSGGTPLHSP LHTPRASPTG TPGTTPPPSP
     GGGVGGAAWR SRLNSIRNSF LGSPRFHRRK MQVPTAEEMS SLTPESSPEL AKRSWFGNFI
     SLDKEEQIFL VLKDKPLSSI KADIVHAFLS IPSLSHSVLS QTSFRAEYKA SGGPSVFQKP
     VRFQVDISSS EGPEPSPRRD GSGGGGIYSV TFTLISGPSR RFKRVVETIQ AQLLSTHDQP
     SVQALADEKN GAQTRPAGAP PRSLQPPPGR PDPELSSSPR RGPPKDKKLL ATNGTPLP
//
